APO Research
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Biologics

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Veterinary Biologics Market Outlook and Growth Opportunities 2026

2 January 2026204 pages

Choose your research edition.

Industry ResearchVeterinary Biologics Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Biologics Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Veterinary Biologics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Biologics Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Biologics Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Veterinary Biologics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Veterinary Biologics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Veterinary Biologics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Veterinary Biologics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Veterinary Biologics market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Veterinary Biologics market include Avimex Animal, Bio-Labs, Boehringer Ingelheim, CAHIC, CAVAC, Ceva, DHN, Elanco/Eli Lilly and FATRO, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Veterinary Biologics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Veterinary Biologics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Veterinary Biologics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Veterinary Biologics market size, projected growth trends, production technologies, key applications, and end-use industries.

Veterinary Biologics Segment by Company

Avimex Animal

Bio-Labs

Boehringer Ingelheim

CAHIC

CAVAC

Ceva

DHN

Elanco/Eli Lilly

FATRO

HVRI

Kyoto Biken

Ringpu Biology

Vaksindo

Virbac

WINSUN

Yebio

Zoetis

ChengDu Tecbond

Jinyu Bio-Technology

Merck

Veterinary Biologics Segment by Type

Vaccines

Monoclonal Antibodies

Veterinary Biologics Segment by Application

Llivestock

Equine

Other

Veterinary Biologics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Veterinary Biologics status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Veterinary Biologics market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Veterinary Biologics significant trends, drivers, influence factors in global and regions.

6. To analyze Veterinary Biologics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Biologics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Biologics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Biologics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Veterinary Biologics market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Veterinary Biologics industry.

Chapter 3: Detailed analysis of Veterinary Biologics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Veterinary Biologics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Veterinary Biologics in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Veterinary Biologics Industry Trends Table 2. Veterinary Biologics Industry Drivers Table 3. Veterinary Biologics Industry Opportunities and Challenges Table 4. Veterinary Biologics Industry Restraints Table 5. Global Veterinary Biologics Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Veterinary Biologics Revenue Share by Company (2021-2026) Table 7. Global Veterinary Biologics Sales Volume by Company (M Units) & (2021-2026) Table 8. Global Veterinary Biologics Sales Volume Share by Company (2021-2026) Table 9. Global Veterinary Biologics Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Veterinary Biologics Company Ranking, (2024-2026) & (USD Million) Table 11. Global Veterinary Biologics Key Company Manufacturing Base & Headquarters Table 12. Global Veterinary Biologics Company, Product Type & Application Table 13. Global Veterinary Biologics Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Veterinary Biologics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Vaccines Table 18. Significant Companies of Monoclonal Antibodies Table 19. Global Veterinary Biologics Sales Volume by Type 2021 VS 2025 VS 2032 (M Units) Table 20. Global Veterinary Biologics Sales Volume by Type (2021-2026) & (M Units) Table 21. Global Veterinary Biologics Sales Volume by Type (2027-2032) & (M Units) Table 22. Global Veterinary Biologics Sales Volume Share by Type (2021-2026) Table 23. Global Veterinary Biologics Sales Volume Share by Type (2027-2032) Table 24. Global Veterinary Biologics Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Veterinary Biologics Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Veterinary Biologics Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Veterinary Biologics Sales Value Share by Type (2021-2026) Table 28. Global Veterinary Biologics Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Llivestock Table 30. Significant Companies of Equine Table 31. Significant Companies of Other Table 32. Global Veterinary Biologics Sales Volume by Application 2021 VS 2025 VS 2032 (M Units) Table 33. Global Veterinary Biologics Sales Volume by Application (2021-2026) & (M Units) Table 34. Global Veterinary Biologics Sales Volume by Application (2027-2032) & (M Units) Table 35. Global Veterinary Biologics Sales Volume Share by Application (2021-2026) Table 36. Global Veterinary Biologics Sales Volume Share by Application (2027-2032) Table 37. Global Veterinary Biologics Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Veterinary Biologics Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Veterinary Biologics Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Veterinary Biologics Sales Value Share by Application (2021-2026) Table 41. Global Veterinary Biologics Sales Value Share by Application (2027-2032) Table 42. Global Veterinary Biologics Sales by Region: 2021 VS 2025 VS 2032 (M Units) Table 43. Global Veterinary Biologics Sales by Region (2021-2026) & (M Units) Table 44. Global Veterinary Biologics Sales Market Share by Region (2021-2026) Table 45. Global Veterinary Biologics Sales by Region (2027-2032) & (M Units) Table 46. Global Veterinary Biologics Sales Market Share by Region (2027-2032) Table 47. Global Veterinary Biologics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Veterinary Biologics Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Veterinary Biologics Sales Value Share by Region (2021-2026) Table 50. Global Veterinary Biologics Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Veterinary Biologics Sales Value Share by Region (2027-2032) Table 52. Global Veterinary Biologics Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Veterinary Biologics Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Veterinary Biologics Sales by Country: 2021 VS 2025 VS 2032 (M Units) Table 55. Global Veterinary Biologics Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Veterinary Biologics Sales by Country (2021-2026) & (M Units) Table 57. Global Veterinary Biologics Sales Market Share by Country (2021-2026) Table 58. Global Veterinary Biologics Sales by Country (2027-2032) & (M Units) Table 59. Global Veterinary Biologics Sales Market Share by Country (2027-2032) Table 60. Global Veterinary Biologics Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Veterinary Biologics Sales Value Market Share by Country (2021-2026) Table 62. Global Veterinary Biologics Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Veterinary Biologics Sales Value Market Share by Country (2027-2032) Table 64. Avimex Animal Company Information Table 65. Avimex Animal Business Overview Table 66. Avimex Animal Veterinary Biologics Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Avimex Animal Veterinary Biologics Product Portfolio Table 68. Avimex Animal Recent Development Table 69. Bio-Labs Company Information Table 70. Bio-Labs Business Overview Table 71. Bio-Labs Veterinary Biologics Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Bio-Labs Veterinary Biologics Product Portfolio Table 73. Bio-Labs Recent Development Table 74. Boehringer Ingelheim Company Information Table 75. Boehringer Ingelheim Business Overview Table 76. Boehringer Ingelheim Veterinary Biologics Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Boehringer Ingelheim Veterinary Biologics Product Portfolio Table 78. Boehringer Ingelheim Recent Development Table 79. CAHIC Company Information Table 80. CAHIC Business Overview Table 81. CAHIC Veterinary Biologics Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. CAHIC Veterinary Biologics Product Portfolio Table 83. CAHIC Recent Development Table 84. CAVAC Company Information Table 85. CAVAC Business Overview Table 86. CAVAC Veterinary Biologics Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. CAVAC Veterinary Biologics Product Portfolio Table 88. CAVAC Recent Development Table 89. Ceva Company Information Table 90. Ceva Business Overview Table 91. Ceva Veterinary Biologics Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Ceva Veterinary Biologics Product Portfolio Table 93. Ceva Recent Development Table 94. DHN Company Information Table 95. DHN Business Overview Table 96. DHN Veterinary Biologics Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. DHN Veterinary Biologics Product Portfolio Table 98. DHN Recent Development Table 99. Elanco/Eli Lilly Company Information Table 100. Elanco/Eli Lilly Business Overview Table 101. Elanco/Eli Lilly Veterinary Biologics Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Elanco/Eli Lilly Veterinary Biologics Product Portfolio Table 103. Elanco/Eli Lilly Recent Development Table 104. FATRO Company Information Table 105. FATRO Business Overview Table 106. FATRO Veterinary Biologics Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. FATRO Veterinary Biologics Product Portfolio Table 108. FATRO Recent Development Table 109. HVRI Company Information Table 110. HVRI Business Overview Table 111. HVRI Veterinary Biologics Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. HVRI Veterinary Biologics Product Portfolio Table 113. HVRI Recent Development Table 114. Kyoto Biken Company Information Table 115. Kyoto Biken Business Overview Table 116. Kyoto Biken Veterinary Biologics Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Kyoto Biken Veterinary Biologics Product Portfolio Table 118. Kyoto Biken Recent Development Table 119. Ringpu Biology Company Information Table 120. Ringpu Biology Business Overview Table 121. Ringpu Biology Veterinary Biologics Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Ringpu Biology Veterinary Biologics Product Portfolio Table 123. Ringpu Biology Recent Development Table 124. Vaksindo Company Information Table 125. Vaksindo Business Overview Table 126. Vaksindo Veterinary Biologics Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Vaksindo Veterinary Biologics Product Portfolio Table 128. Vaksindo Recent Development Table 129. Virbac Company Information Table 130. Virbac Business Overview Table 131. Virbac Veterinary Biologics Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Virbac Veterinary Biologics Product Portfolio Table 133. Virbac Recent Development Table 134. WINSUN Company Information Table 135. WINSUN Business Overview Table 136. WINSUN Veterinary Biologics Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. WINSUN Veterinary Biologics Product Portfolio Table 138. WINSUN Recent Development Table 139. Yebio Company Information Table 140. Yebio Business Overview Table 141. Yebio Veterinary Biologics Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Yebio Veterinary Biologics Product Portfolio Table 143. Yebio Recent Development Table 144. Zoetis Company Information Table 145. Zoetis Business Overview Table 146. Zoetis Veterinary Biologics Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Zoetis Veterinary Biologics Product Portfolio Table 148. Zoetis Recent Development Table 149. ChengDu Tecbond Company Information Table 150. ChengDu Tecbond Business Overview Table 151. ChengDu Tecbond Veterinary Biologics Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. ChengDu Tecbond Veterinary Biologics Product Portfolio Table 153. ChengDu Tecbond Recent Development Table 154. Jinyu Bio-Technology Company Information Table 155. Jinyu Bio-Technology Business Overview Table 156. Jinyu Bio-Technology Veterinary Biologics Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 157. Jinyu Bio-Technology Veterinary Biologics Product Portfolio Table 158. Jinyu Bio-Technology Recent Development Table 159. Merck Company Information Table 160. Merck Business Overview Table 161. Merck Veterinary Biologics Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 162. Merck Veterinary Biologics Product Portfolio Table 163. Merck Recent Development Table 164. Key Raw Materials Table 165. Raw Materials Key Suppliers Table 166. Veterinary Biologics Distributors List Table 167. Veterinary Biologics Customers List Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources Table 171. Primary Sources List of Figures Figure 1. Veterinary Biologics Product Image Figure 2. Global Veterinary Biologics Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary Biologics Sales Value (2021-2032) & (US$ Million) Figure 4. Global Veterinary Biologics Sales (2021-2032) & (M Units) Figure 5. Global Veterinary Biologics Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Veterinary Biologics Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Vaccines Image Figure 10. Monoclonal Antibodies Image Figure 11. Global Veterinary Biologics Sales Volume by Type (2021 VS 2025 VS 2032) & (M Units) Figure 12. Global Veterinary Biologics Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Veterinary Biologics Sales Volume Share by Type (2021-2032) Figure 14. Global Veterinary Biologics Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Veterinary Biologics Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Veterinary Biologics Sales Value Share by Type (2021-2032) Figure 17. Llivestock Image Figure 18. Equine Image Figure 19. Other Image Figure 20. Global Veterinary Biologics Sales Volume by Application (2021 VS 2025 VS 2032) & (M Units) Figure 21. Global Veterinary Biologics Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Veterinary Biologics Sales Volume Share by Application (2021-2032) Figure 23. Global Veterinary Biologics Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Veterinary Biologics Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Veterinary Biologics Sales Value Share by Application (2021-2032) Figure 26. Global Veterinary Biologics Sales by Region: 2021 VS 2025 VS 2032 (M Units) Figure 27. Global Veterinary Biologics Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Veterinary Biologics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Veterinary Biologics Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Veterinary Biologics Sales Value (2021-2032) & (US$ Million) Figure 31. North America Veterinary Biologics Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Veterinary Biologics Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Veterinary Biologics Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Veterinary Biologics Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Veterinary Biologics Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Veterinary Biologics Sales Value (2021-2032) & (US$ Million) Figure 37. South America Veterinary Biologics Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Veterinary Biologics Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Veterinary Biologics Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Veterinary Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Veterinary Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Veterinary Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Veterinary Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Veterinary Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Veterinary Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Veterinary Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Veterinary Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Veterinary Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Veterinary Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Veterinary Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Veterinary Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Veterinary Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Veterinary Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Veterinary Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Veterinary Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Veterinary Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Veterinary Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Veterinary Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Veterinary Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Veterinary Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Veterinary Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Veterinary Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Veterinary Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Veterinary Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Veterinary Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Veterinary Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Veterinary Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Veterinary Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Veterinary Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Veterinary Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Veterinary Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Veterinary Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Veterinary Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Veterinary Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Veterinary Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Veterinary Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Veterinary Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Veterinary Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Veterinary Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Veterinary Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Veterinary Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Veterinary Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Veterinary Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Veterinary Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Veterinary Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Veterinary Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Veterinary Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Veterinary Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Veterinary Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Veterinary Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Veterinary Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Veterinary Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Veterinary Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Veterinary Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Veterinary Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Veterinary Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Veterinary Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Veterinary Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Veterinary Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Veterinary Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Veterinary Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Veterinary Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Veterinary Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Veterinary Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Veterinary Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Veterinary Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Veterinary Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Veterinary Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Veterinary Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Veterinary Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Veterinary Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Veterinary Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Veterinary Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Veterinary Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Veterinary Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Veterinary Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Veterinary Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Veterinary Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Veterinary Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Veterinary Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Veterinary Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Veterinary Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Veterinary Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Veterinary Biologics Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Veterinary Biologics Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Vaccines
  • Monoclonal Antibodies
Applications
  • Llivestock
  • Equine
  • Other
Companies covered
  • Avimex Animal
  • Bio-Labs
  • Boehringer Ingelheim
  • CAHIC
  • CAVAC
  • Ceva
  • DHN
  • Elanco/Eli Lilly
  • FATRO
  • HVRI
  • Kyoto Biken
  • Ringpu Biology
  • Vaksindo
  • Virbac
  • WINSUN
  • Yebio
  • Zoetis
  • ChengDu Tecbond
  • Jinyu Bio-Technology
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Veterinary Biologics Sales Value (2021-2032)
  4. 1.2.2 Global Veterinary Biologics Sales Volume (2021-2032)
  5. 1.2.3 Global Veterinary Biologics Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Veterinary Biologics Market Dynamics
  1. 2.1 Veterinary Biologics Industry Trends
  2. 2.2 Veterinary Biologics Industry Drivers
  3. 2.3 Veterinary Biologics Industry Opportunities and Challenges
  4. 2.4 Veterinary Biologics Industry Restraints
3 Veterinary Biologics Market by Company
  1. 3.1 Global Veterinary Biologics Company Revenue Ranking in 2025
  2. 3.2 Global Veterinary Biologics Revenue by Company (2021-2026)
  3. 3.3 Global Veterinary Biologics Sales Volume by Company (2021-2026)
  4. 3.4 Global Veterinary Biologics Average Price by Company (2021-2026)
  5. 3.5 Global Veterinary Biologics Company Ranking (2024-2026)
  6. 3.6 Global Veterinary Biologics Company Manufacturing Base and Headquarters
  7. 3.7 Global Veterinary Biologics Company Product Type and Application
  8. 3.8 Global Veterinary Biologics Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Veterinary Biologics Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Veterinary Biologics Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Veterinary Biologics Market by Type
  1. 4.1 Veterinary Biologics Type Introduction
  2. 4.1.1 Vaccines
  3. 4.1.2 Monoclonal Antibodies
  4. 4.2 Global Veterinary Biologics Sales Volume by Type
  5. 4.2.1 Global Veterinary Biologics Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Veterinary Biologics Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Veterinary Biologics Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Veterinary Biologics Sales Value by Type
  9. 4.3.1 Global Veterinary Biologics Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Veterinary Biologics Sales Value by Type (2021-2032)
  11. 4.3.3 Global Veterinary Biologics Sales Value Share by Type (2021-2032)
5 Veterinary Biologics Market by Application
  1. 5.1 Veterinary Biologics Application Introduction
  2. 5.1.1 Llivestock
  3. 5.1.2 Equine
  4. 5.1.3 Other
  5. 5.2 Global Veterinary Biologics Sales Volume by Application
  6. 5.2.1 Global Veterinary Biologics Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Veterinary Biologics Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Veterinary Biologics Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Veterinary Biologics Sales Value by Application
  10. 5.3.1 Global Veterinary Biologics Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Veterinary Biologics Sales Value by Application (2021-2032)
  12. 5.3.3 Global Veterinary Biologics Sales Value Share by Application (2021-2032)
6 Veterinary Biologics Regional Sales and Value Analysis
  1. 6.1 Global Veterinary Biologics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Veterinary Biologics Sales by Region (2021-2032)
  3. 6.2.1 Global Veterinary Biologics Sales by Region: 2021-2026
  4. 6.2.2 Global Veterinary Biologics Sales by Region (2027-2032)
  5. 6.3 Global Veterinary Biologics Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Veterinary Biologics Sales Value by Region (2021-2032)
  7. 6.4.1 Global Veterinary Biologics Sales Value by Region: 2021-2026
  8. 6.4.2 Global Veterinary Biologics Sales Value by Region (2027-2032)
  9. 6.5 Global Veterinary Biologics Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Veterinary Biologics Sales Value (2021-2032)
  12. 6.6.2 North America Veterinary Biologics Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Veterinary Biologics Sales Value (2021-2032)
  15. 6.7.2 Europe Veterinary Biologics Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Veterinary Biologics Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Veterinary Biologics Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Veterinary Biologics Sales Value (2021-2032)
  21. 6.9.2 South America Veterinary Biologics Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Veterinary Biologics Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Veterinary Biologics Sales Value Share by Country, 2025 VS 2032
7 Veterinary Biologics Country-level Sales and Value Analysis
  1. 7.1 Global Veterinary Biologics Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Veterinary Biologics Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Veterinary Biologics Sales by Country (2021-2032)
  4. 7.3.1 Global Veterinary Biologics Sales by Country (2021-2026)
  5. 7.3.2 Global Veterinary Biologics Sales by Country (2027-2032)
  6. 7.4 Global Veterinary Biologics Sales Value by Country (2021-2032)
  7. 7.4.1 Global Veterinary Biologics Sales Value by Country (2021-2026)
  8. 7.4.2 Global Veterinary Biologics Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Veterinary Biologics Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Veterinary Biologics Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Veterinary Biologics Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Veterinary Biologics Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Veterinary Biologics Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Veterinary Biologics Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Veterinary Biologics Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Veterinary Biologics Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Veterinary Biologics Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Veterinary Biologics Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Veterinary Biologics Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Veterinary Biologics Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Veterinary Biologics Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Veterinary Biologics Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Veterinary Biologics Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Veterinary Biologics Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Veterinary Biologics Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Veterinary Biologics Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Veterinary Biologics Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Veterinary Biologics Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Veterinary Biologics Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Veterinary Biologics Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Veterinary Biologics Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Veterinary Biologics Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Veterinary Biologics Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Veterinary Biologics Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Veterinary Biologics Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Veterinary Biologics Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Veterinary Biologics Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Veterinary Biologics Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Veterinary Biologics Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Veterinary Biologics Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Veterinary Biologics Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Veterinary Biologics Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Veterinary Biologics Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Veterinary Biologics Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Veterinary Biologics Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Veterinary Biologics Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Veterinary Biologics Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Veterinary Biologics Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Veterinary Biologics Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Veterinary Biologics Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Veterinary Biologics Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Veterinary Biologics Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Veterinary Biologics Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Veterinary Biologics Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Veterinary Biologics Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Veterinary Biologics Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Veterinary Biologics Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Veterinary Biologics Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Veterinary Biologics Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Veterinary Biologics Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Veterinary Biologics Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Veterinary Biologics Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Veterinary Biologics Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Veterinary Biologics Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Veterinary Biologics Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Veterinary Biologics Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Veterinary Biologics Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Veterinary Biologics Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Veterinary Biologics Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Veterinary Biologics Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Veterinary Biologics Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Veterinary Biologics Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Veterinary Biologics Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Veterinary Biologics Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Veterinary Biologics Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Veterinary Biologics Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Veterinary Biologics Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Veterinary Biologics Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Veterinary Biologics Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Veterinary Biologics Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Veterinary Biologics Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Veterinary Biologics Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Veterinary Biologics Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Veterinary Biologics Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Veterinary Biologics Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Veterinary Biologics Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Veterinary Biologics Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Veterinary Biologics Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Veterinary Biologics Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Veterinary Biologics Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Veterinary Biologics Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Veterinary Biologics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Avimex Animal
  2. 8.1.1 Avimex Animal Company Information
  3. 8.1.2 Avimex Animal Business Overview
  4. 8.1.3 Avimex Animal Veterinary Biologics Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Avimex Animal Veterinary Biologics Product Portfolio
  6. 8.1.5 Avimex Animal Recent Developments
  7. 8.2 Bio-Labs
  8. 8.2.1 Bio-Labs Company Information
  9. 8.2.2 Bio-Labs Business Overview
  10. 8.2.3 Bio-Labs Veterinary Biologics Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Bio-Labs Veterinary Biologics Product Portfolio
  12. 8.2.5 Bio-Labs Recent Developments
  13. 8.3 Boehringer Ingelheim
  14. 8.3.1 Boehringer Ingelheim Company Information
  15. 8.3.2 Boehringer Ingelheim Business Overview
  16. 8.3.3 Boehringer Ingelheim Veterinary Biologics Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Boehringer Ingelheim Veterinary Biologics Product Portfolio
  18. 8.3.5 Boehringer Ingelheim Recent Developments
  19. 8.4 CAHIC
  20. 8.4.1 CAHIC Company Information
  21. 8.4.2 CAHIC Business Overview
  22. 8.4.3 CAHIC Veterinary Biologics Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 CAHIC Veterinary Biologics Product Portfolio
  24. 8.4.5 CAHIC Recent Developments
  25. 8.5 CAVAC
  26. 8.5.1 CAVAC Company Information
  27. 8.5.2 CAVAC Business Overview
  28. 8.5.3 CAVAC Veterinary Biologics Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 CAVAC Veterinary Biologics Product Portfolio
  30. 8.5.5 CAVAC Recent Developments
  31. 8.6 Ceva
  32. 8.6.1 Ceva Company Information
  33. 8.6.2 Ceva Business Overview
  34. 8.6.3 Ceva Veterinary Biologics Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Ceva Veterinary Biologics Product Portfolio
  36. 8.6.5 Ceva Recent Developments
  37. 8.7 DHN
  38. 8.7.1 DHN Company Information
  39. 8.7.2 DHN Business Overview
  40. 8.7.3 DHN Veterinary Biologics Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 DHN Veterinary Biologics Product Portfolio
  42. 8.7.5 DHN Recent Developments
  43. 8.8 Elanco/Eli Lilly
  44. 8.8.1 Elanco/Eli Lilly Company Information
  45. 8.8.2 Elanco/Eli Lilly Business Overview
  46. 8.8.3 Elanco/Eli Lilly Veterinary Biologics Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Elanco/Eli Lilly Veterinary Biologics Product Portfolio
  48. 8.8.5 Elanco/Eli Lilly Recent Developments
  49. 8.9 FATRO
  50. 8.9.1 FATRO Company Information
  51. 8.9.2 FATRO Business Overview
  52. 8.9.3 FATRO Veterinary Biologics Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 FATRO Veterinary Biologics Product Portfolio
  54. 8.9.5 FATRO Recent Developments
  55. 8.10 HVRI
  56. 8.10.1 HVRI Company Information
  57. 8.10.2 HVRI Business Overview
  58. 8.10.3 HVRI Veterinary Biologics Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 HVRI Veterinary Biologics Product Portfolio
  60. 8.10.5 HVRI Recent Developments
  61. 8.11 Kyoto Biken
  62. 8.11.1 Kyoto Biken Company Information
  63. 8.11.2 Kyoto Biken Business Overview
  64. 8.11.3 Kyoto Biken Veterinary Biologics Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Kyoto Biken Veterinary Biologics Product Portfolio
  66. 8.11.5 Kyoto Biken Recent Developments
  67. 8.12 Ringpu Biology
  68. 8.12.1 Ringpu Biology Company Information
  69. 8.12.2 Ringpu Biology Business Overview
  70. 8.12.3 Ringpu Biology Veterinary Biologics Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Ringpu Biology Veterinary Biologics Product Portfolio
  72. 8.12.5 Ringpu Biology Recent Developments
  73. 8.13 Vaksindo
  74. 8.13.1 Vaksindo Company Information
  75. 8.13.2 Vaksindo Business Overview
  76. 8.13.3 Vaksindo Veterinary Biologics Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Vaksindo Veterinary Biologics Product Portfolio
  78. 8.13.5 Vaksindo Recent Developments
  79. 8.14 Virbac
  80. 8.14.1 Virbac Company Information
  81. 8.14.2 Virbac Business Overview
  82. 8.14.3 Virbac Veterinary Biologics Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Virbac Veterinary Biologics Product Portfolio
  84. 8.14.5 Virbac Recent Developments
  85. 8.15 WINSUN
  86. 8.15.1 WINSUN Company Information
  87. 8.15.2 WINSUN Business Overview
  88. 8.15.3 WINSUN Veterinary Biologics Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 WINSUN Veterinary Biologics Product Portfolio
  90. 8.15.5 WINSUN Recent Developments
  91. 8.16 Yebio
  92. 8.16.1 Yebio Company Information
  93. 8.16.2 Yebio Business Overview
  94. 8.16.3 Yebio Veterinary Biologics Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Yebio Veterinary Biologics Product Portfolio
  96. 8.16.5 Yebio Recent Developments
  97. 8.17 Zoetis
  98. 8.17.1 Zoetis Company Information
  99. 8.17.2 Zoetis Business Overview
  100. 8.17.3 Zoetis Veterinary Biologics Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Zoetis Veterinary Biologics Product Portfolio
  102. 8.17.5 Zoetis Recent Developments
  103. 8.18 ChengDu Tecbond
  104. 8.18.1 ChengDu Tecbond Company Information
  105. 8.18.2 ChengDu Tecbond Business Overview
  106. 8.18.3 ChengDu Tecbond Veterinary Biologics Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 ChengDu Tecbond Veterinary Biologics Product Portfolio
  108. 8.18.5 ChengDu Tecbond Recent Developments
  109. 8.19 Jinyu Bio-Technology
  110. 8.19.1 Jinyu Bio-Technology Company Information
  111. 8.19.2 Jinyu Bio-Technology Business Overview
  112. 8.19.3 Jinyu Bio-Technology Veterinary Biologics Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Jinyu Bio-Technology Veterinary Biologics Product Portfolio
  114. 8.19.5 Jinyu Bio-Technology Recent Developments
  115. 8.20 Merck
  116. 8.20.1 Merck Company Information
  117. 8.20.2 Merck Business Overview
  118. 8.20.3 Merck Veterinary Biologics Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Merck Veterinary Biologics Product Portfolio
  120. 8.20.5 Merck Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Veterinary Biologics Value Chain Analysis
  2. 9.1.1 Veterinary Biologics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Veterinary Biologics Sales Mode & Process
  6. 9.2 Veterinary Biologics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Veterinary Biologics Distributors
  9. 9.2.3 Veterinary Biologics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst